Connection

Michael Hallek to Risk Assessment

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Risk Assessment.
Michael Hallek
Connection Strength
0.049
Risk Assessment
  1. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2017 Sep; 92(9):946-965.
    View in: PubMed
    Score: 0.031
  2. Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill. 2020 05; 25(21).
    View in: PubMed
    Score: 0.009
  3. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Leuk Lymphoma. 2019 06; 60(6):1438-1446.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.